1. Shteinberg M, Haq IJ, Polineni D, Davies JC. Cystic fibrosis. Lancet 2021; 397: 2195-2211.
2. Chen Q, Shen Y, Zheng J. A review of cystic fibrosis: basic and clinical aspects. Animal Model Exp Med 2021; 4: 220-232.
3. Lopes-Pacheco M. CFTR Modulators: the changing face of cystic fibrosis in the era of precision medicine. Front Pharmacol 2020; 10: 1662.
4. Vandevanter DR, Kahle JS, O’Sullivan AK, Sikirica S, Hodgkins PS. Cystic fibrosis in young children: a review of disease manifestation, progression, and response to early treatment. J Cyst Fibros 2016; 15: 147-157.
5. Galante G, Freeman AJ. Gastrointestinal, pancreatic, and hepatic manifestations of cystic fibrosis in the newborn. Neoreviews 2019; 20(1): e12-e24.
6. Davies JC, Alton EW, Bush A. Cystic fibrosis. BMJ 2007; 335: 1255-1259.
7. Keogh RH, Szczesniak R, Taylor-Robinson D, Bilton D. Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: a longitudinal study using UK patient registry data. J Cyst Fibros 2018; 17: 218-227.
8. Zolin A, Bossi A, Cirilli N, Kashirskaya N, Padoan R. Cystic fibrosis mortality in childhood. Data from European Cystic Fibrosis Society Patient Registry. Int J Environ Res Public Health 2018; 15: 2020.
9. Turcios NL. Cystic fibrosis lung disease: an overview. Respir Care 2020; 65: 233-251.
10. Bergeron C, Cantin AM. Cystic fibrosis: pathophysiology of lung disease. Semin Respir Crit Care Med 2019; 40: 715-726.
11. Walshaw MJ. Cystic fibrosis: diagnosis and management–NICE guideline 78. Paediatr Respir Rev 2019; 31: 12-14.
12. Cohen RWF, Folescu TW, Boechat MCB, Fonseca VM, Marques EA, Leão RS. High-resolution computed tomography findings in young infants with cystic fibrosis detected by newborn screening. Clinics (Sao Paulo) 2019; 74: e1399.
13. Petrocheilou A, Papagrigoriou-Theodoridou M, Michos A, Doudounakis S-E, Loukou I, Kaditis A. Early-life Pseudomonas aeruginosa infection in cystic fibrosis and lung disease progression. Glob Pediatr Health 2017; 4: 2333794X17738465.
14. Zampoli M, Verstraete J, Frauendorf M, Kassanjee R, Workman L, Morrow BM, et al. Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome. ERJ Open Res 2021; 7: 00856-2020.
15. Thomas M, Raja M, Albakri M, Najim M, Chandra P, Allangawi M. CT score and correlation with lung function and microbiology of adult patients with cystic fibrosis with predominant I1234V genotype in Qatar. Qatar Med J 2020; 2020: 4.
16. Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, et al. Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation. J Pediatr 2017; 181S: S4-S15. e1.
17. Woods JC, Wild JM, Wielpütz MO, Clancy JP, Hatabu H, Kauczor HU, et al. Current state of the art MRI for the longitudinal assessment of cystic fibrosis. J Magn Reson Imaging 2020; 52: 1306-1320.
18. Scotet V, L’Hostis C, Férec C. The changing epidemiology of cystic fibrosis: incidence, survival and impact of the cftr gene discovery. Genes (Basel) 2020; 11: 589.
19. Bhagirath AY, Li Y, Somayajula D, Dadashi M, Badr S, Duan K. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. BMC Pulm Med 2016; 16: 174.
20. Palmer KL, Mashburn LM, Singh PK, Whiteley M. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 2005; 187: 5267-5277.
21. Khanbabaee G, Akbarizadeh M, Sayyari A, Ashayeri-Panah M, Abdollahgorji F, Sheibani K, et al. A survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients. Braz J Infect Dis 2012; 16: 122-128.
22. Khodadad A, Najafi M, Daneshjoo F, Ashtiani MT, Movahedi M, Sadr M, et al. Pulmonary Pseudomonas colonization in cystic fibrosis. Tanaffos 2006; 5: 41-48.
23. Montagna MT, Barbuti G, Paglionico F, Lovero G, Iatta R, De Giglio O, et al. Retrospective analysis of microorganisms isolated from cystic fibrosis patients in outhern Italy, 2002-2010. J Prev Med Hyg 2011; 52: 209-214.
24. Kołodziej M, de Veer MJ, Cholewa M, Egan GF, Thompson BR. Lung function imaging methods in cystic fibrosis pulmonary disease. Respir Res 2017; 18: 96.
25. Pereira FF, Ibiapina CC, Alvim CG, Camargos PA, Figueiredo R, Pedrosa JF. Correlation between Bhalla score and spirometry in children and adolescents with cystic fibrosis. Rev Assoc Med Bras (1992) 2014; 60: 216-221.
26. Marchant JM, Masel JP, Dickinson FL, Masters IB, Chang AB. Application of chest high-resolution computer tomography in young children with cystic fibrosis. Pediatr Pulmonol 2001; 31: 24-29.
27. Sasihuseyinoglu AS, Altıntaş DU, Soyupak S, Dogruel D, Yılmaz M, Serbes M, et al. Evaluation of high resolution computed tomography findings of cystic fibrosis. Korean J Intern Med 2019; 34: 335-343.
28. Robinson TE, Leung AN, Chen X, Moss RB, Emond MJ. Cystic fibrosis HRCT scores correlate strongly with Pseudomonas infection. Pediatr Pulmonol 2009; 44: 1107-1117.
29. Chai Y-H, Xu J-F. How does Pseudomonas aeruginosa affect the progression of bronchiectasis? Clin Microbiol Infect 2020; 26: 313-318.
30. Cuthbertson L, Walker AW, Oliver AE, Rogers GB, Rivett DW, Hampton TH, et al. Lung function and microbiota diversity in cystic fibrosis. Microbiome 2020; 8: 45.
31. Dediu M, Ciuca IM, Marc MS, Boeriu E, Pop LL. Factors influencing lung function in patients with cystic fibrosis in Western Romania. J Multidiscip Healthc 2021; 14: 1423-1429.
32. Kerem E, Viviani L, Zolin A, MacNeill S, Hatziagorou E, Ellemunter H, et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. Eur Respir J 2014; 43: 125-133.
33. Davies G, Wells AU, Doman S, Watanabe S, Wilson R. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J 2006; 28: 974-979.